Statement attributable to:

Susan R. Bailey, M.D.

American Medical Association President

“The AMA applauds the Biden administration for lifting unnecessary restrictions that required in-person dispensing of mifepristone amid the COVID-19 pandemic. This move ensures the health and safety of patients seeking access to the drug, especially those from marginalized communities that have been hardest hit by the pandemic. We are pleased that the reversal of this rule, which the AMA and other leading health organizations called for in letters and litigation, supports physicians’ ability to provide safe, high quality, accessible reproductive care for our patients.”

Media Contact:

AMA Media & Editorial

ph: (312) 464-4430

[email protected]

About the American Medical Association

The American Medical Association is the physicians’ powerful ally in patient care. As the only medical association that convenes 190+ state and specialty medical societies and other critical stakeholders, the AMA represents physicians with a unified voice to all key players in health care.  The AMA leverages its strength by removing the obstacles that interfere with patient care, leading the charge to prevent chronic disease and confront public health crises and, driving the future of medicine to tackle the biggest challenges in health care.